Answers are grounded in this paper and cite their sources.
The prevalence of bronchial asthma and allergic rhinitis has been on the rise in India. Cannabis is reported to be one of the allergenically important airborne pollen identified by the clinico-immunologic evaluation in the spring season in India. We report a case of 38-year-old male patient with typical clinical manifestations of bronchial asthma and allergic rhinitis that classically exacerbates during the pollination period of Cannabis . On evaluation, the patient was found to be significantly sensitized to Cannabis sativa . Subsequent subcutaneous immunotherapy leads to marked improvement in control of asthma as well as improved quality-of-life.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: